by Portfolio Grader | November 15, 2012 2:45 pm
Three Life Science stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).
Life Technologies (NASDAQ:LIFE) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Life Technologies offers a broad range of products and services, including systems, instruments, reagents, and custom services. In Portfolio Grader’s specific subcategory of Cash Flow, LIFE also gets an A. For more information, get Portfolio Grader’s complete analysis of LIFE stock.
PerkinElmer (NYSE:PKI) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. PerkinElmer provides technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services market. For more information, get Portfolio Grader’s complete analysis of PKI stock.
WuXi PharmaTech (NYSE:WX) improves from a C to a B rating this week. WuXi PharmaTech operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company primarily in the Peoples Republic of China and the United States. Shares of WX have increased 10% over the past month, better than the 5.9% decrease the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of WX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
Source URL: http://investorplace.com/2012/11/3-life-science-stocks-to-buy-now-life-pki-wx/
Short URL: http://invstplc.com/1hTOQoj
Copyright ©2014 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.